Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
Clinical trial NCT06680050 · RECRUITING
Trial details
- NCT number
- NCT06680050
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-07
- Primary completion
- 2028-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.